Breaking News Instant updates and real-time market news.

ASMB

Assembly Biosciences

$39.70

-0.22 (-0.55%)

16:08
07/10/18
07/10
16:08
07/10/18
16:08

Assembly Biosciences announces offering of 3M shares of common stock

Assembly Biosciences announced that it intends to offer and sell, subject to market and other conditions, 3M shares of its common stock in an underwritten public offering. Jefferies, Leerink Partners, William Blair & Company, and Mizuho Securities are acting as joint bookrunning managers for the offering. Robert W. Baird is acting as lead manager for the offering.

ASMB Assembly Biosciences
$39.70

-0.22 (-0.55%)

03/08/18
JEFF
03/08/18
NO CHANGE
Target $75
JEFF
Buy
Assembly Biosciences price target raised to $75 from $50 at Jefferies
Jefferies analyst Michael Yee raised his price target for Assembly Biosciences to $75 and keeps a Buy rating on the shares. The analyst continues to like Assembly as a top smid-cap biotech idea given "emerging promising data" for core protein inhibitors in Hepatitis B, its "own strong and growing" pipeline with data catalysts this year, and "significant" market opportunity. Further, the analyst sees the company's $120M cash position as sufficient to move beyond 2018 and fund large Phase II studies.
04/12/18
JEFF
04/12/18
NO CHANGE
Target $75
JEFF
Buy
New data from Assembly Biosciences look 'great,' says Jefferies
Assembly Biosciences presented this morning positive detailed results from its Phase IB study of oral ABI-H0731 in chronic hepatitis B patients, Jefferies analyst Michael Yee tells investors in a research note titled "New EASL Data Looks Great - Potent Efficacy Across HBV Populations - BUY." He believes the data show potent efficacy and dose response across hepatitis B patients as well as clean safety and tolerability. The analyst thinks Assembly "will increasingly be getting on the map" of big pharma and large biotech. The company remains an attractive takeover candidate for big companies in the anti-viral space as its drugs are "starting to play out," Yee contends. He keeps a Buy rating on Assembly Biosciences with a $75 price target.
04/13/18
CHDN
04/13/18
DOWNGRADE
CHDN
Neutral
Assembly Biosciences downgraded to Neutral from Buy at Chardan
04/13/18
WBLR
04/13/18
NO CHANGE
WBLR
Outperform
Assembly Biosciences fair value estimate raised to $84 from $52 at William Blair
William Blair analyst Y. Katherine Xu raised her fair value estimate of Assembly Biosciences shares to $84 from $52 after the company presented interim Phase Ib data for candidate ABI-H0731. The potency seen so far with ABI-H0731 represents the best-in-class among the congenital pulmonary airway malformation candidates in the clinic, Xu tells investors in a research note. The analyst increased the probability of success for Assembly's CpAM class to become a component of some future hepatitis B virus curing regimens to 40% from 20%. The analyst keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

JCP

J.C. Penney

$2.50

-0.065 (-2.53%)

16:23
07/20/18
07/20
16:23
07/20/18
16:23
Hot Stocks
J.C. Penney chief customer officer McFarland to leave company »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
07/20/18
07/20
16:20
07/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for July 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASFI

Asta Funding

$3.15

-0.1 (-3.08%)

16:18
07/20/18
07/20
16:18
07/20/18
16:18
Hot Stocks
Asta Funding receives Nasdaq non-compliance letter »

Asta Funding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
07/20/18
07/20
16:17
07/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
07/20/18
07/20
16:16
07/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

16:15
07/20/18
07/20
16:15
07/20/18
16:15
Periodicals
Disney fires 'Guardians' director after controversial tweets, THR says »

Disney has fired James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MSFT

Microsoft

, GE

General Electric

16:15
07/20/18
07/20
16:15
07/20/18
16:15
General news
Fly Intel: Wall Street's top stories for Friday »

Stocks began the day…

MSFT

Microsoft

GE

General Electric

HON

Honeywell

PAH

Platform Specialty Products

GSK

GlaxoSmithKline

PTCT

PTC Therapeutics

LLNW

Limelight Networks

VFC

VF Corp.

SKX

Skechers

STT

State Street

SWKS

Skyworks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 04

    Sep

MYL

Mylan

$35.57

-0.08 (-0.22%)

, AGN

Allergan

$171.85

-1.53 (-0.88%)

16:12
07/20/18
07/20
16:12
07/20/18
16:12
Hot Stocks
PTAB rules in favor of Mylan to allow Restasis challenge to proceed »

Mylan (MYL) announced…

MYL

Mylan

$35.57

-0.08 (-0.22%)

AGN

Allergan

$171.85

-1.53 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Nov

CEI

Camber Energy

$0.45

-0.0236 (-5.03%)

16:07
07/20/18
07/20
16:07
07/20/18
16:07
Hot Stocks
Breaking Hot Stocks news story on Camber Energy  »

Discover Growth Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JONE

Jones Energy

$0.38

-0.0117 (-3.02%)

16:06
07/20/18
07/20
16:06
07/20/18
16:06
Hot Stocks
Jones Energy names Carl Giesler, Jr. CEO »

Jones Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$87.26

-0.14 (-0.16%)

16:01
07/20/18
07/20
16:01
07/20/18
16:01
Periodicals
Third Point looking into new PayPal investment, Dealreporter says »

Third Point is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 15

    Aug

  • 16

    Aug

BLK

BlackRock

$502.28

-2.15 (-0.43%)

16:01
07/20/18
07/20
16:01
07/20/18
16:01
Hot Stocks
BlackRock CEO Fink discloses sale of $10.1M in stock »

BlackRock CEO Laurence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$93.33

4.12 (4.62%)

15:50
07/20/18
07/20
15:50
07/20/18
15:50
Options
Defensive option play in VF Corp as shares spike on earnings »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BAC

Bank of America

$30.06

0.4 (1.35%)

15:40
07/20/18
07/20
15:40
07/20/18
15:40
Options
Biggest option block of the day is in Bank of America »

Biggest option block of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$41.82

1.125 (2.76%)

15:30
07/20/18
07/20
15:30
07/20/18
15:30
Periodicals
GSK tells Bloomberg three business structure offers 'significant opportunities' »

Glaxosmithkline told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GE

General Electric

$13.14

-0.59 (-4.30%)

15:30
07/20/18
07/20
15:30
07/20/18
15:30
Options
Heavy trading in GE options as shares face renewed selling pressure »

Heavy trading in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

WSM

Williams-Sonoma

$61.73

-1.01 (-1.61%)

15:25
07/20/18
07/20
15:25
07/20/18
15:25
Options
Williams Sonoma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$322.13

2.46 (0.77%)

15:24
07/20/18
07/20
15:24
07/20/18
15:24
Periodicals
Lockheed Martin's F-35 to play bigger role in Europe defense, Reuters says »

U.S. and European defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

IWM

iShares Trust Russell 2000 Index Fund

$168.82

-0.32 (-0.19%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:20
07/20/18
07/20
15:20
07/20/18
15:20
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 Index…

IWM

iShares Trust Russell 2000 Index Fund

$168.82

-0.32 (-0.19%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
07/20/18
07/20
15:20
07/20/18
15:20
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TCF

TCF Financial

$25.35

-0.05 (-0.20%)

15:18
07/20/18
07/20
15:18
07/20/18
15:18
Hot Stocks
TCF Bank enters BFCP settlement with CFPB to resolve litigation »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
07/20/18
07/20
15:17
07/20/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
07/20/18
07/20
15:16
07/20/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.90

-0.05 (-0.02%)

15:09
07/20/18
07/20
15:09
07/20/18
15:09
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX), at…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.90

-0.05 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$43.08

0.2 (0.47%)

15:05
07/20/18
07/20
15:05
07/20/18
15:05
Options
AFLAC call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.